BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) was the recipient of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 240,100 shares, a drop of 43.0% from the May 15th total of 421,400 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 541,100 shares, the days-to-cover ratio is presently 0.4 days.
BlackRock Capital Allocation Term Trust Price Performance
Shares of NYSE:BCAT traded up $0.08 during midday trading on Wednesday, hitting $14.83. The stock had a trading volume of 240,806 shares, compared to its average volume of 453,665. The company's 50-day moving average price is $14.62 and its 200-day moving average price is $15.05. BlackRock Capital Allocation Term Trust has a fifty-two week low of $12.91 and a fifty-two week high of $17.06.
BlackRock Capital Allocation Term Trust Cuts Dividend
The company also recently disclosed a monthly dividend, which will be paid on Monday, June 30th. Investors of record on Friday, June 13th will be paid a $0.2782 dividend. The ex-dividend date is Friday, June 13th. This represents a $3.34 dividend on an annualized basis and a yield of 22.51%.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Comerica Bank boosted its holdings in shares of BlackRock Capital Allocation Term Trust by 6.7% in the 1st quarter. Comerica Bank now owns 10,805 shares of the company's stock valued at $156,000 after purchasing an additional 679 shares in the last quarter. Ameriprise Financial Inc. lifted its position in shares of BlackRock Capital Allocation Term Trust by 1.9% during the 4th quarter. Ameriprise Financial Inc. now owns 44,528 shares of the company's stock worth $675,000 after buying an additional 844 shares during the last quarter. Amplius Wealth Advisors LLC boosted its stake in BlackRock Capital Allocation Term Trust by 5.4% in the first quarter. Amplius Wealth Advisors LLC now owns 29,005 shares of the company's stock valued at $418,000 after buying an additional 1,492 shares in the last quarter. Cerity Partners LLC boosted its stake in BlackRock Capital Allocation Term Trust by 4.6% in the first quarter. Cerity Partners LLC now owns 41,832 shares of the company's stock valued at $602,000 after buying an additional 1,832 shares in the last quarter. Finally, Noble Wealth Management PBC bought a new position in BlackRock Capital Allocation Term Trust in the first quarter valued at about $32,000. 36.12% of the stock is currently owned by institutional investors and hedge funds.
About BlackRock Capital Allocation Term Trust
(
Get Free Report)
-
Recommended Stories
Before you consider BlackRock Capital Allocation Term Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock Capital Allocation Term Trust wasn't on the list.
While BlackRock Capital Allocation Term Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
